Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.

Corrado Blandizzi1

  • 1Divisione di Farmacologia e Chemioterapia, Dipartimento di Medicina Interna, Università di Pisa, Via Roma 55, 56126 Pisa, Italy. c.blandizzi@med.unipi.it

Neurochemistry International
|July 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy.

Frontiers in pharmacology·2023
Same author

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Role of cyclooxygenase pathways in bowel fibrotic remodelling in a murine model of experimental colitis.

The Journal of pharmacy and pharmacology·2022
Same author

Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study.

Journal of clinical medicine·2021
Same author

Donepezil improves vascular function in a mouse model of Alzheimer's disease.

Pharmacology research & perspectives·2021
Same author

Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases.

Scientific reports·2021

Alpha2-adrenoceptors regulate digestive functions and are implicated in irritable bowel syndrome and post-operative ileus. Targeting these receptors may offer therapeutic benefits for gut disorders.

Area of Science:

  • Gastroenterology
  • Neurogastroenterology
  • Pharmacology

Background:

  • The gastrointestinal tract is regulated by extrinsic noradrenergic nerves activating alpha2-adrenoceptors.
  • Alpha2-adrenoceptors modulate digestive functions, including motility, secretion, and sensation.
  • Distinct alpha2-adrenoceptor subtypes (alpha2A, alpha2B, alpha2C) exist, with alpha2A predominant in the gut.

Purpose of the Study:

  • To review the pathophysiological roles of enteric alpha2-adrenoceptors.
  • To explore potential therapeutic applications of targeting alpha2-adrenoceptors in gastrointestinal disorders.

Main Methods:

  • Literature review of studies on alpha2-adrenoceptor function in the gut.
  • Analysis of clinical and experimental evidence regarding alpha2-adrenoceptor involvement in digestive diseases.

Related Experiment Videos

  • Examination of genetic associations with alpha2-adrenoceptor gene polymorphisms.

    • Main Results:

    • Alpha2-adrenoceptor activation favorably influences colonic tone and sensation, aiding irritable bowel syndrome symptoms.
    • Alpha2-adrenoceptors in post-operative ileus models contribute to gut dysfunction and inflammation.
    • Enteric alpha2-adrenoceptor expression is upregulated in intestinal inflammation, causing motor alterations.

    Conclusions:

    • Enteric alpha2-adrenoceptors play significant roles in normal digestion and disease states.
    • Targeting alpha2-adrenoceptors presents a promising therapeutic strategy for various gastrointestinal conditions, including IBS and post-operative ileus.